• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Evernorth Announces New Cost and Transparency Protections for its Express Scripts Patients

    1/29/25 9:00:00 AM ET
    $CI
    Medical Specialities
    Health Care
    Get the next $CI alert in real time by email
    • Actions aim to lower patient out-of-pocket costs



    • Expands transparency for both patients and those who provide their benefits

    BLOOMFIELD, Conn., Jan. 29, 2025 /PRNewswire/ -- Evernorth Health Services, a subsidiary of The Cigna Group (NYSE:CI), today announced several steps it is taking to improve costs and transparency around pharmacy benefits. These changes aim to help patients benefit directly from Express Scripts' negotiations to lower the cost of prescription drugs. They will also enhance transparency about these negotiations for both patients and those who provide their benefits.

    Evernorth Health Services (PRNewsfoto/Evernorth Health Services)

    "We know that health care and prescription drugs need to be more affordable, and that coverage needs to be more transparent and less complex," said Eric Palmer, President and CEO of Evernorth Health Services. "While we advocate for the lowest costs for the more than 100 million Americans we serve, we know there are times where the system falls short. We hear the concerns of patients, plan sponsors and the public, and are making these commitments as one step to do more to help patients get their medications at the lowest cost and improve transparency to enable more informed choices."

    Today, Evernorth is implementing protections to help lower costs for patients at the pharmacy counter.

    Helping All Patients Benefit Directly from Express Scripts' Drug Price Negotiations

    While today more than 80% of Express Scripts' patients pay less than $100 per year for their prescriptions, for some out-of-pocket costs still remain too high. This is especially true for patients in high deductible plans who may face the high list prices of medicines set by manufacturers.

    Evernorth is implementing protections to lower out-of-pocket costs for more patients. These actions are designed to help ensure patients receive the benefit of the savings Express Scripts generates through its negotiations. Going forward, Evernorth's standard offerings will provide the following protections:

    1.  Patients will be protected from paying the high list price of their medication, and will instead get access to the lower price negotiated by Express Scripts.

    2.  Patients in employer-sponsored plans will have improved financial predictability, receiving the benefit of the savings on medication costs that Express Scripts negotiates, if they don't already. This will be particularly meaningful to patients during their deductible phase when the cost of medications can be at their highest. 

    Providing Patients and Plan Sponsors with New Pharmacy Benefits Summaries and Disclosures

    Express Scripts is also improving transparency through new reports which will:

    3.  Provide patients a personalized summary that details each patient's annual total prescription drug costs, including medication prices, negotiated savings inclusive of discounts and rebates, plan paid amounts, and total savings.

    4.  Provide plan sponsors with an annual standardized report disclosing costs and pharmacy claim-level reporting, which will create additional transparency beyond the routine reporting and insights Express Scripts already delivers.

    "It is our goal to always exceed patient expectations for better health and to ensure there are no surprises at the pharmacy counter," said Adam Kautzner, Pharm.D., President of Evernorth Care Management and Express Scripts. "We want to do our part to lead change so patients can afford their medications and understand how their pharmacy benefits are working for them."

    About Evernorth Health Services

    Evernorth Health Services creates pharmacy, care and benefits solutions to improve health and increase vitality. We relentlessly innovate to make the prediction, prevention and treatment of illness and disease more accessible to millions of people. Evernorth capabilities are powered by our businesses, including Express Scripts, Express Scripts® Pharmacy, Accredo, EviCore and MDLIVE, along with holistic Evernorth platforms and solutions that move people and organizations forward. All Evernorth solutions are serviced and provided by or through operating affiliates of Evernorth Health, a wholly owned subsidiary of The Cigna Group (NYSE:CI), or third-party partners. Learn more at evernorth.com.

    Media Contact

    Justine Sessions

    860-810-6523

    [email protected] 

    Cision View original content to download multimedia:https://www.prnewswire.com/news-releases/evernorth-announces-new-cost-and-transparency-protections-for-its-express-scripts-patients-302363210.html

    SOURCE Evernorth

    Get the next $CI alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $CI

    DatePrice TargetRatingAnalyst
    10/14/2025$370.00Buy
    Goldman
    2/6/2025$323.00Outperform → Mkt Perform
    Bernstein
    6/26/2024$400.00Overweight
    Piper Sandler
    5/30/2024$388.00Outperform
    Robert W. Baird
    3/6/2024$393.00Overweight
    Barclays
    2/5/2024$334.00 → $372.00Neutral → Overweight
    Cantor Fitzgerald
    2/5/2024$327.00 → $354.00Sector Perform → Outperform
    RBC Capital Mkts
    2/1/2024$355.00 → $370.00Hold → Buy
    Deutsche Bank
    More analyst ratings

    $CI
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Goldman initiated coverage on The Cigna Group with a new price target

    Goldman initiated coverage of The Cigna Group with a rating of Buy and set a new price target of $370.00

    10/14/25 8:47:37 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group downgraded by Bernstein with a new price target

    Bernstein downgraded The Cigna Group from Outperform to Mkt Perform and set a new price target of $323.00

    2/6/25 7:05:01 AM ET
    $CI
    Medical Specialities
    Health Care

    Piper Sandler initiated coverage on The Cigna Group with a new price target

    Piper Sandler initiated coverage of The Cigna Group with a rating of Overweight and set a new price target of $400.00

    6/26/24 7:28:18 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chairman & CEO Cordani David bought $999,916 worth of shares (4,134 units at $241.88) (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    11/3/25 2:47:56 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Director Kurian George

    4 - Cigna Group (0001739940) (Issuer)

    12/2/25 5:07:40 PM ET
    $CI
    Medical Specialities
    Health Care

    Chairman & CEO Cordani David bought $999,916 worth of shares (4,134 units at $241.88) (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    11/3/25 2:47:56 PM ET
    $CI
    Medical Specialities
    Health Care

    Officer Evanko Brian C exercised 6,269 shares at a strike of $139.22 and sold $1,610,400 worth of shares (5,368 units at $300.00), increasing direct ownership by 2% to 52,083 units (SEC Form 4)

    4 - Cigna Group (0001739940) (Issuer)

    10/7/25 5:22:53 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Evernorth Health Services Teams Up with Direct Relief To Deliver Critical Medications to Communities Impacted by Disasters

    Evernorth's home delivery pharmacy donated more than 41,000 prescription medications to Direct Relief for initial supply Collaboration creates a scalable, replicable model for pharmacies to support disaster preparedness and future humanitarian responseBLOOMFIELD, Conn., Feb. 12, 2026 /PRNewswire/ -- Evernorth, the health services division of The Cigna Group (NYSE:CI), has partnered with Direct Relief to donate more than 41,000 lifesaving prescription medications for rapid deployment during natural disasters and other emergencies. Through this collaboration, Evernorth's Express Scripts Pharmacy has created a first–of–its–kind donation pathway that enables humanitarian organizations to source

    2/12/26 9:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend

    Total revenues for 2025 increased 11% to $274.9 billionShareholders' net income for 2025 was $6.0 billion, or $22.18 per shareAdjusted income from operations1 for 2025 was $8.0 billion, or $29.84 per share2026 adjusted income from operations1 is projected to be at least $7.950 billion, or at least $30.25 per share2Board of Directors declared an increase in the quarterly dividend to $1.56 per shareBLOOMFIELD, Conn., Feb. 5, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported 2025 results, underscoring operational discipline and the strength of its complimentary portfolio of global health businesses.

    2/5/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    VINCENT COUNTRY SAFE ZONE ACTIVITY DAY PRESENTED BY CIGNA HEALTHCARE DELIVERS SUPER BOWL WEEK FUN, NFL FLAG FOOTBALL, AND WELLNESS TO OAKLAND STUDENTS

    Corporate, Nonprofit, and Philanthropic Partners Collaborated to Provide Transformative Experiences and Lasting Resources at Burckhalter Elementary School OAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare, a flagship initiative of Love Thy Neighbor CDC co-founded by NFL Executive and Legend Troy Vincent, Sr. and his wife, author and chef Tommi A. Vincent, took place Tuesday, February 3, at Burckhalter Elementary School in Oakland, CA. The ninth annual event, themed Dreams Grow Here, delivered a full day of fun, food, wellness, and engaging sports activities, including NFL FLAG, for more than 200 Pre-K through fifth-grade studen

    2/3/26 8:17:00 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    SEC Filings

    View All

    SEC Form 144 filed by The Cigna Group

    144 - Cigna Group (0001739940) (Subject)

    2/6/26 2:05:58 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

    8-K - Cigna Group (0001739940) (Filer)

    2/5/26 6:15:54 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group filed SEC Form 8-K: Other Events

    8-K - Cigna Group (0001739940) (Filer)

    11/18/25 4:15:46 PM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Financials

    Live finance-specific insights

    View All

    The Cigna Group Reports Strong Fourth Quarter and Full Year 2025 Results, Establishes 2026 Outlook and Increases Dividend

    Total revenues for 2025 increased 11% to $274.9 billionShareholders' net income for 2025 was $6.0 billion, or $22.18 per shareAdjusted income from operations1 for 2025 was $8.0 billion, or $29.84 per share2026 adjusted income from operations1 is projected to be at least $7.950 billion, or at least $30.25 per share2Board of Directors declared an increase in the quarterly dividend to $1.56 per shareBLOOMFIELD, Conn., Feb. 5, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported 2025 results, underscoring operational discipline and the strength of its complimentary portfolio of global health businesses.

    2/5/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group's Fourth Quarter 2025 Earnings Release Details

    BLOOMFIELD, Conn., Jan. 13, 2026 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) will release its fourth quarter 2025 financial results on Thursday, February 5, 2026, and will host a conference call the same day. Fourth quarter 2025 financial results will be released no later than 6:30 a.m. Eastern Time (ET). Management will review these results on a conference call beginning at 8:30 a.m. ET. The call-in numbers are as follows: Live Call (888) 566-1889 (Domestic) (773) 799-3989 (International) Passcode: 02052026 Replay (866) 405-7290 (Domestic) (203) 369-0603 (

    1/13/26 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Reports Strong Third Quarter 2025 Results, Reaffirms 2025 Adjusted EPS Outlook

    Total revenues for the third quarter 2025 increased 10% to $69.7 billionShareholders' net income for the third quarter 2025 was $1.9 billion, or $6.98 per shareAdjusted income from operations1 for the third quarter 2025 was $2.1 billion, or $7.83 per shareReaffirms 2025 outlook for adjusted income from operations1,2 of at least $29.60 per share2The Cigna Group announced a new rebate-free pharmacy benefit model designed to lower costs, improve transparency, and support local pharmaciesBLOOMFIELD, Conn., Oct. 30, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) today reported third quarter 2025 results that reflect strategic execution across its diverse portfolio of busines

    10/30/25 6:00:00 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G filed by The Cigna Group

    SC 13G - Cigna Group (0001739940) (Subject)

    11/12/24 9:55:14 AM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by The Cigna Group (Amendment)

    SC 13G/A - Cigna Group (0001739940) (Subject)

    2/13/24 5:02:29 PM ET
    $CI
    Medical Specialities
    Health Care

    SEC Form SC 13G/A filed by The Cigna Group (Amendment)

    SC 13G/A - Cigna Group (0001739940) (Subject)

    2/9/24 8:50:20 AM ET
    $CI
    Medical Specialities
    Health Care

    $CI
    Leadership Updates

    Live Leadership Updates

    View All

    VINCENT COUNTRY SAFE ZONE ACTIVITY DAY PRESENTED BY CIGNA HEALTHCARE DELIVERS SUPER BOWL WEEK FUN, NFL FLAG FOOTBALL, AND WELLNESS TO OAKLAND STUDENTS

    Corporate, Nonprofit, and Philanthropic Partners Collaborated to Provide Transformative Experiences and Lasting Resources at Burckhalter Elementary School OAKLAND, Calif., Feb. 3, 2026 /PRNewswire/ -- Vincent Country Safe Zone Activity Day Presented by Cigna Healthcare, a flagship initiative of Love Thy Neighbor CDC co-founded by NFL Executive and Legend Troy Vincent, Sr. and his wife, author and chef Tommi A. Vincent, took place Tuesday, February 3, at Burckhalter Elementary School in Oakland, CA. The ninth annual event, themed Dreams Grow Here, delivered a full day of fun, food, wellness, and engaging sports activities, including NFL FLAG, for more than 200 Pre-K through fifth-grade studen

    2/3/26 8:17:00 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group Announces Appointment of Michael J. Hennigan to Board of Directors

    BLOOMFIELD, Conn., June 2, 2025 /PRNewswire/ -- Global health company The Cigna Group (NYSE:CI) announced today that Michael J. Hennigan has been appointed to the organization's Board of Directors. His appointment is effective June 2. Mr. Hennigan is the Executive Chairman of Marathon Petroleum Corporation (MPC), an integrated downstream energy company, and MPLX, a diversified master limited partnership formed by MPC. He joined the company in 2017 and previously held the roles of Chief Executive Officer of MPC and Chairman, President and Chief Executive Officer of MPLX. Prior

    6/2/25 4:30:00 PM ET
    $CI
    Medical Specialities
    Health Care

    The Cigna Group's "Community Vitality Project" Donates $75,000 to Nonprofits through Program Encouraging Fitness and Community Engagement

    As part of the company's initiative, thousands of employees logged 280,000 minutes of exercise over nine days Cigna leaders biked to Hartford, Conn.'s Dunkin' Park to host Boys & Girls Clubs members for a Yard Goats baseball game, with surprise appearances by UConn basketball coach and playersBLOOMFIELD, Conn., Sept. 9, 2024 /PRNewswire/ -- The Cigna Group (NYSE:CI) put out a challenge to its workforce this summer, inviting colleagues to join its first-ever Community Vitality Project, a nine-day challenge combining fun, fitness and fundraising. By logging more than 280,000 minutes of fitness activities and awarding their minutes spent moving, The Cigna Group employees helped determine how to

    9/9/24 7:00:00 AM ET
    $CI
    Medical Specialities
    Health Care